Mounjaro vs Trulicity: How Do These GLP-1 Medications Compare for Weight Loss?
With obesity impacting over 40% of American adults, the demand for effective weight loss medications continues growing. Recently, newer glucagon-like peptide-1 (GLP-1) receptor agonists like tirzepatide (Mounjaro) and dulaglutide (Trulicity) have gained attention for their promising weight loss potential.
Understanding GLP-1 Medications
GLP-1 drugs are a class of injectable diabetes medications that activate GLP-1 receptors which stimulate insulin production while suppressing appetite. By impacting blood sugar levels and satiety, they offer weight loss side effects beneficial to diabetics and non-diabetics alike.
While all GLP-1 drugs promote some degree of weight loss, Mounjaro and Trulicity have distinctly promising effects. But how do these two compare for supporting weight management?
Key Similarities and Differences
As GLP-1 agonists, Mounjaro and Trulicity share common traits like:
- Once weekly injection dosing
- Used along with diet/exercise, not a standalone obesity treatment
- May cause temporary GI side effects like nausea and vomiting
- Require prescription and monitoring by healthcare provider
They differ primarily in their chemical makeup impacting comparative efficacy and safety profiles:
- Mounjaro - recently approved, contains tirzepatide which dual activates GLP-1 and glucose dependent insulinotropic polypeptide (GIP) receptors
- Trulicity - contains dulaglutide and mainly stimulates GLP-1 receptors only
Analysis of Available Clinical Trial Evidence
Head-to-head clinical trials directly comparing Mounjaro and Trulicity for weight loss do not yet exist. However, data from separate clinical studies provides insight into their respective weight change efficacy and safety.
Mounjaro for Weight Loss
In Mounjaros SURMOUNT phase 3 trials with non-diabetic obese adults on calorie-controlled diets over 68 weeks, key findings included:
- Average weight loss of 12-25% body weight depending on dosing
- Up to 51 pounds lost on highest dose (15mg)
- Over 2/3 of participants losing 10% body weight
- Reduced BMI, waist circumference and body fat
- Most common side effects were GI related - nausea, vomiting, diarrhea
Additionally, a study directly comparing Mounjaro to Wegovy (higher dose semaglutide) over 68 weeks found nearly identical weight reduction effects further demonstrating Mounjaros potency for obesity.
Trulicity for Weight Loss
In Trulicitys clinical trials of type 2 diabetics, weight change findings included:
- Average 5-7% weight loss from baseline sustained up to 3 years
- Only ~1/3 of users losing 10% baseline weight
- Reduced BMI and waist circumference measurements
- Low risk for hypoglycemia (low blood sugar)
- Common side effects - nausea, diarrhea, vomiting, decreased appetite
While Trulicity promotes modest clinically meaningful weight loss over long-term, effects appear less substantial compared to newer agents like Mounjaro.
Comparing Safety Profiles
Both medications demonstrate overall positive safety and tolerability data, although risks differ slightly:
- Mounjaro - increased heart rate, blood pressure, diabetic retinopathy risk need monitoring
- Trulicity - precautions with thyroid C-cell tumors, pancreatitis, renal impairment
Talk to your provider regarding complete risks vs benefits analysis before using.
Key Considerations for Use
When considering Mounjaro vs Trulicity for managing excess weight, key factors include:
1. Efficacy
With ~3 times greater weight loss results in trials, Mounjaro appears significantly more effective although real world data needs confirming this.
2. Cost and Insurance Coverage
Being brand new, Mounjaro costs over $1,000 per month without insurance. Trulicity runs $800-900 without coverage. Both require prior authorization with insurance before reduced copays.
3. Side Effect Profile
Both demonstrate overall safe use but need proper physician oversight for optimal management of temporary GI effects and select long term health risks requiring monitoring.
4. Treatment Goals
Trulicitys moderate efficacy suits those seeking 5-10% weight reduction. Mounjaro benefits more obese patients requiring 15%+ loss along with diet and lifestyle interventions.
Deciding Between Mounjaro vs Trulicity
When considering weight management approaches, consult your doctor regarding benefits vs limitations of using Mounjaro, Trulicity or other GLP-1 drugs. While both promote loss, Mounjaro shows particular promise achieving more substantial reductions in clinical trials that may prove superior pending additional real world evidence.
FAQs
How much weight can you lose on Mounjaro?
In clinical trials, people lost an average of 12-25% of their body weight on Mounjaro depending on dosing. Those on the highest dose lost up to 51 lbs (15mg).
Does Trulicity work better than other GLP-1 drugs?
Trulicity appears less potent than newer GLP-1 drugs like Mounjaro for weight loss. It promotes about 5-7% baseline weight reduction compared to 12-25% with Mounjaro in studies.
What are the main side effects of Mounjaro and Trulicity?
Both medications commonly cause temporary GI issues like nausea, vomiting and diarrhea. Mounjaro also increases heart rate/blood pressure needing monitoring.
Does insurance cover Mounjaro or Trulicity?
Both Mounjaro and Trulicity require prior authorization for insurance coverage. Without insurance they cost over $800-1000 per month out of pocket.
Who should consider Mounjaro vs Trulicity?
Trulicity suits those seeking modest 5-10% weight loss. Mounjaro benefits more obese patients needing 15%+ reductions along with diet and exercise modifications.
Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult with a healthcare professional before starting any new treatment regimen.
Add Comment